Cargando…

SUN-423 Nonhemorrhagic Pituitary Apoplexy Following CABG Surgery

Introduction: Pituitary apoplexy (PA) is a rare syndrome resulting from acute infarction, hemorrhage, or edema of the pituitary gland. Due to a wide variety of nonspecific symptoms and number of precipitating triggers, diagnosis can be challenging. Thus, a high level of suspicion must be maintained....

Descripción completa

Detalles Bibliográficos
Autores principales: Aftab, Hassaan, Zia, Bushra, Thim, Monica, Malhotra, Neha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552786/
http://dx.doi.org/10.1210/js.2019-SUN-423
_version_ 1783424667819704320
author Aftab, Hassaan
Zia, Bushra
Thim, Monica
Malhotra, Neha
author_facet Aftab, Hassaan
Zia, Bushra
Thim, Monica
Malhotra, Neha
author_sort Aftab, Hassaan
collection PubMed
description Introduction: Pituitary apoplexy (PA) is a rare syndrome resulting from acute infarction, hemorrhage, or edema of the pituitary gland. Due to a wide variety of nonspecific symptoms and number of precipitating triggers, diagnosis can be challenging. Thus, a high level of suspicion must be maintained. Cardiac surgery with the utilization of cardiopulmonary bypass is a unique cause of PA that has an interesting pathophysiologic mechanism as an inciting factor. Knowledge of this is important as PA is a life-threatening condition with significant morbidity and mortality, especially in the perioperative period. Case: A 68-year-old male with a history of coronary artery disease status post recent coronary artery bypass graft presented on post-operative day 2 with acute blurry vision and visual field defects and remarkably no headache. MRI Brain revealed a heterogeneous intra- and suprasellar mass measuring 2.4 x 2.7 x 2.5 cm and expansion of the sella turcica with impingement of the optic chiasm, concerning for non-hemorrhagic PA in a previously undiagnosed pituitary macroadenoma. Laboratory workup was consistent with panhypopituitarism (except for central DI) for which he was immediately started on hormone replacement therapy with hydrocortisone and levothyroxine. Due to contraindication for surgery, fractionated intensity modulated radiation therapy was initiated delivering a total of 5400cGy of radiation in 30 fractions over 6 weeks. Serial post-radiation MRIs demonstrated dramatic decrease in pituitary macroadenoma size to 1.6 x 0.5 x 1.4 cm with complete resolution of sellar expansion, optic chiasm compression and his visual symptoms. Discussion: PA is a life-threatening syndrome that typically occurs in the setting of a pre-existing pituitary adenoma. Clinical diagnosis is made based upon sudden onset of symptoms within the syndrome of panhypopituitarism. Uniquely, cardiac surgery has been postulated as a cause of PA due to acute tumor expansion from cardiopulmonary bypass dynamics, which allow for infarction as a result of hemodilution, hypotension, and/or microembolism. PA is a clinical diagnosis which requires radiological confirmation with MRI with a sensitivity of 89-94%. Cases without signs of pituitary hemorrhage have a less severe clinical presentation and a better outcome. PA must be managed urgently by hormonal replacement. Definitive treatment is with surgical decompression and transphenoidal resection or radiotherapy. Radiotherapy is an option for refractory disease or non-surgical candidates showing excellent rates of local tumor control for non-functioning adenomas in particular. Due to its associated morbidity and mortality, it is important for clinicians to recognize PA as a rare perioperative complication of CABG that requires a high level of clinical suspicion to allow for prompt radiographic workup and treatment to ensure quality patient care.
format Online
Article
Text
id pubmed-6552786
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65527862019-06-13 SUN-423 Nonhemorrhagic Pituitary Apoplexy Following CABG Surgery Aftab, Hassaan Zia, Bushra Thim, Monica Malhotra, Neha J Endocr Soc Neuroendocrinology and Pituitary Introduction: Pituitary apoplexy (PA) is a rare syndrome resulting from acute infarction, hemorrhage, or edema of the pituitary gland. Due to a wide variety of nonspecific symptoms and number of precipitating triggers, diagnosis can be challenging. Thus, a high level of suspicion must be maintained. Cardiac surgery with the utilization of cardiopulmonary bypass is a unique cause of PA that has an interesting pathophysiologic mechanism as an inciting factor. Knowledge of this is important as PA is a life-threatening condition with significant morbidity and mortality, especially in the perioperative period. Case: A 68-year-old male with a history of coronary artery disease status post recent coronary artery bypass graft presented on post-operative day 2 with acute blurry vision and visual field defects and remarkably no headache. MRI Brain revealed a heterogeneous intra- and suprasellar mass measuring 2.4 x 2.7 x 2.5 cm and expansion of the sella turcica with impingement of the optic chiasm, concerning for non-hemorrhagic PA in a previously undiagnosed pituitary macroadenoma. Laboratory workup was consistent with panhypopituitarism (except for central DI) for which he was immediately started on hormone replacement therapy with hydrocortisone and levothyroxine. Due to contraindication for surgery, fractionated intensity modulated radiation therapy was initiated delivering a total of 5400cGy of radiation in 30 fractions over 6 weeks. Serial post-radiation MRIs demonstrated dramatic decrease in pituitary macroadenoma size to 1.6 x 0.5 x 1.4 cm with complete resolution of sellar expansion, optic chiasm compression and his visual symptoms. Discussion: PA is a life-threatening syndrome that typically occurs in the setting of a pre-existing pituitary adenoma. Clinical diagnosis is made based upon sudden onset of symptoms within the syndrome of panhypopituitarism. Uniquely, cardiac surgery has been postulated as a cause of PA due to acute tumor expansion from cardiopulmonary bypass dynamics, which allow for infarction as a result of hemodilution, hypotension, and/or microembolism. PA is a clinical diagnosis which requires radiological confirmation with MRI with a sensitivity of 89-94%. Cases without signs of pituitary hemorrhage have a less severe clinical presentation and a better outcome. PA must be managed urgently by hormonal replacement. Definitive treatment is with surgical decompression and transphenoidal resection or radiotherapy. Radiotherapy is an option for refractory disease or non-surgical candidates showing excellent rates of local tumor control for non-functioning adenomas in particular. Due to its associated morbidity and mortality, it is important for clinicians to recognize PA as a rare perioperative complication of CABG that requires a high level of clinical suspicion to allow for prompt radiographic workup and treatment to ensure quality patient care. Endocrine Society 2019-04-30 /pmc/articles/PMC6552786/ http://dx.doi.org/10.1210/js.2019-SUN-423 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Neuroendocrinology and Pituitary
Aftab, Hassaan
Zia, Bushra
Thim, Monica
Malhotra, Neha
SUN-423 Nonhemorrhagic Pituitary Apoplexy Following CABG Surgery
title SUN-423 Nonhemorrhagic Pituitary Apoplexy Following CABG Surgery
title_full SUN-423 Nonhemorrhagic Pituitary Apoplexy Following CABG Surgery
title_fullStr SUN-423 Nonhemorrhagic Pituitary Apoplexy Following CABG Surgery
title_full_unstemmed SUN-423 Nonhemorrhagic Pituitary Apoplexy Following CABG Surgery
title_short SUN-423 Nonhemorrhagic Pituitary Apoplexy Following CABG Surgery
title_sort sun-423 nonhemorrhagic pituitary apoplexy following cabg surgery
topic Neuroendocrinology and Pituitary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552786/
http://dx.doi.org/10.1210/js.2019-SUN-423
work_keys_str_mv AT aftabhassaan sun423nonhemorrhagicpituitaryapoplexyfollowingcabgsurgery
AT ziabushra sun423nonhemorrhagicpituitaryapoplexyfollowingcabgsurgery
AT thimmonica sun423nonhemorrhagicpituitaryapoplexyfollowingcabgsurgery
AT malhotraneha sun423nonhemorrhagicpituitaryapoplexyfollowingcabgsurgery